Prevalence of occult hepatitis C virus infection (OCI) among hemodialysis patients; a cross–sectional study from Lorestan Province, Western Iran

Patients with chronic kidney disorders, such as hemodialysis, are at a higher risk of infection with hepatitis viruses than the other population due to high nosocomial transmission by the dialysis units. The incidence of occult HCV infection (OCI) among chronic hemodialysis (CHD) remains controversi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virusdisease 2024-09, Vol.35 (3), p.478-483
Hauptverfasser: Hasanvand, Banafsheh, Mirzaei, Habibollah, Hadian, Babak, sasaei, parsa, Garavand, Sara, Adhikary, Hemanta, Khanizadeh, Sayyad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 483
container_issue 3
container_start_page 478
container_title Virusdisease
container_volume 35
creator Hasanvand, Banafsheh
Mirzaei, Habibollah
Hadian, Babak
sasaei, parsa
Garavand, Sara
Adhikary, Hemanta
Khanizadeh, Sayyad
description Patients with chronic kidney disorders, such as hemodialysis, are at a higher risk of infection with hepatitis viruses than the other population due to high nosocomial transmission by the dialysis units. The incidence of occult HCV infection (OCI) among chronic hemodialysis (CHD) remains controversial and the real burden of HCV in this population may be affected by the rate of OCI. This study aimed to evaluate the prevalence of OCI among patients with CHD from Lorestan province, Western Iran. In this cross-sectional study, whole blood samples were collected from 122 patients with CHD. Subsequently, anti- HCV antibody and HCV -RNA were assessed in serum/peripheral blood mononuclear cells (PBMCs) using Enzyme-Linked Immunosorbent Assay and Real-Time PCR technique, respectively. Out of the 122 patients, 61.15% were male and 38.8% were female. Regarding HCV results, out of the 122 studied patients, 4 cases (3.3%) were positive for anti-HCV IgM Ab and 3 patients (2.47%) for anti- HCV IgG Ab in their serum. Moreover, none of the 122 patients were positive for HCV -RNA in serum samples, while in PBMC samples, two patients (1.6%) tested positive for HCV -RNA, of which one patient was anti- HCV IgG Ab positive. Furthermore, the prevalence of OCI was correlated with the history of blood transfusion and serum level of transaminases ( P  = 0.012). The results of the current study suggest that there is a potential risk of occult HCV infection among patients undergoing hemodialysis. Therefore, it is necessary to use appropriate molecular techniques for early diagnosis and treatment of these patients.
doi_str_mv 10.1007/s13337-024-00881-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3154152172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3121282554</sourcerecordid><originalsourceid>FETCH-LOGICAL-c204y-bd67b31862db6ccc8cd033ff1ca46d3192ac1cbecc072dd9d1bcbd8273b8ac473</originalsourceid><addsrcrecordid>eNqNkc1q3TAQhUVpaEKSF-iiCLpJoU71Z8umq3Dpz4ULyaKlSyGP5FTBlm4l-4J3fYbmDfMkVa7TFLIoXY0YfefMMAehl5ScU0Lku0Q557IgTBSE1DUt5mfoiHEhC15S-fzxXYtDdJrSDSGEUilE1bxAh7wRlZBMHqFfV9HudG89WBw6HACmfsTf7VaPbnQJr_DOxSlh5zsLowsen12u1m-wHoK_ztwQjNP9nDJ6L7F-TO-xxhBDSnc_b9Mi0j1O42Rm3MUw4E2INo3a46sYdi5Pfou_5YaNHq-j9ifooNN9sqcP9Rh9_fjhy-pzsbn8tF5dbApgRMxFayrZclpXzLQVANRgCOddR0GLynDaMA0UWgtAJDOmMbSF1tRM8rbWICQ_RmeL7zaGH1NeQA0uge177W2YkuK0FLRkVLL_QBllNStLkdHXT9CbMMV8gT1FGCUNbzLFFmp_qGg7tY1u0HFWlKj7fNWSr8r5qn2-as6iVw_WUztY8yj5k2YG-AKk_OWvbfw7-x-2vwHEY7Pm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120210939</pqid></control><display><type>article</type><title>Prevalence of occult hepatitis C virus infection (OCI) among hemodialysis patients; a cross–sectional study from Lorestan Province, Western Iran</title><source>SpringerLink Journals</source><creator>Hasanvand, Banafsheh ; Mirzaei, Habibollah ; Hadian, Babak ; sasaei, parsa ; Garavand, Sara ; Adhikary, Hemanta ; Khanizadeh, Sayyad</creator><creatorcontrib>Hasanvand, Banafsheh ; Mirzaei, Habibollah ; Hadian, Babak ; sasaei, parsa ; Garavand, Sara ; Adhikary, Hemanta ; Khanizadeh, Sayyad</creatorcontrib><description>Patients with chronic kidney disorders, such as hemodialysis, are at a higher risk of infection with hepatitis viruses than the other population due to high nosocomial transmission by the dialysis units. The incidence of occult HCV infection (OCI) among chronic hemodialysis (CHD) remains controversial and the real burden of HCV in this population may be affected by the rate of OCI. This study aimed to evaluate the prevalence of OCI among patients with CHD from Lorestan province, Western Iran. In this cross-sectional study, whole blood samples were collected from 122 patients with CHD. Subsequently, anti- HCV antibody and HCV -RNA were assessed in serum/peripheral blood mononuclear cells (PBMCs) using Enzyme-Linked Immunosorbent Assay and Real-Time PCR technique, respectively. Out of the 122 patients, 61.15% were male and 38.8% were female. Regarding HCV results, out of the 122 studied patients, 4 cases (3.3%) were positive for anti-HCV IgM Ab and 3 patients (2.47%) for anti- HCV IgG Ab in their serum. Moreover, none of the 122 patients were positive for HCV -RNA in serum samples, while in PBMC samples, two patients (1.6%) tested positive for HCV -RNA, of which one patient was anti- HCV IgG Ab positive. Furthermore, the prevalence of OCI was correlated with the history of blood transfusion and serum level of transaminases ( P  = 0.012). The results of the current study suggest that there is a potential risk of occult HCV infection among patients undergoing hemodialysis. Therefore, it is necessary to use appropriate molecular techniques for early diagnosis and treatment of these patients.</description><identifier>ISSN: 2347-3584</identifier><identifier>EISSN: 2347-3517</identifier><identifier>DOI: 10.1007/s13337-024-00881-y</identifier><identifier>PMID: 39464727</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Antibodies ; Biochemistry ; Biomedical and Life Sciences ; Blood levels ; blood serum ; Blood transfusion ; Blood transfusions ; Cell Biology ; Chronic infection ; cross infection ; Cross-sectional studies ; dialysis ; early diagnosis ; Enzyme-linked immunosorbent assay ; Enzymes ; females ; Gender ; Hemodialysis ; Hepatitis C ; Immunoglobulin G ; Immunoglobulin M ; Infections ; Iran ; Kidney diseases ; kidneys ; Leukocytes (mononuclear) ; Life Sciences ; Liver diseases ; males ; Microbiology ; Original Article ; Patients ; Peripheral blood mononuclear cells ; Population ; Population studies ; Protein Structure ; quantitative polymerase chain reaction ; Ribonucleic acid ; risk ; RNA ; Statistical analysis ; transaminases ; Viral infections</subject><ispartof>Virusdisease, 2024-09, Vol.35 (3), p.478-483</ispartof><rights>The Author(s), under exclusive licence to Indian Virological Society 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c204y-bd67b31862db6ccc8cd033ff1ca46d3192ac1cbecc072dd9d1bcbd8273b8ac473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13337-024-00881-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s13337-024-00881-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39464727$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasanvand, Banafsheh</creatorcontrib><creatorcontrib>Mirzaei, Habibollah</creatorcontrib><creatorcontrib>Hadian, Babak</creatorcontrib><creatorcontrib>sasaei, parsa</creatorcontrib><creatorcontrib>Garavand, Sara</creatorcontrib><creatorcontrib>Adhikary, Hemanta</creatorcontrib><creatorcontrib>Khanizadeh, Sayyad</creatorcontrib><title>Prevalence of occult hepatitis C virus infection (OCI) among hemodialysis patients; a cross–sectional study from Lorestan Province, Western Iran</title><title>Virusdisease</title><addtitle>VirusDis</addtitle><addtitle>Virusdisease</addtitle><description>Patients with chronic kidney disorders, such as hemodialysis, are at a higher risk of infection with hepatitis viruses than the other population due to high nosocomial transmission by the dialysis units. The incidence of occult HCV infection (OCI) among chronic hemodialysis (CHD) remains controversial and the real burden of HCV in this population may be affected by the rate of OCI. This study aimed to evaluate the prevalence of OCI among patients with CHD from Lorestan province, Western Iran. In this cross-sectional study, whole blood samples were collected from 122 patients with CHD. Subsequently, anti- HCV antibody and HCV -RNA were assessed in serum/peripheral blood mononuclear cells (PBMCs) using Enzyme-Linked Immunosorbent Assay and Real-Time PCR technique, respectively. Out of the 122 patients, 61.15% were male and 38.8% were female. Regarding HCV results, out of the 122 studied patients, 4 cases (3.3%) were positive for anti-HCV IgM Ab and 3 patients (2.47%) for anti- HCV IgG Ab in their serum. Moreover, none of the 122 patients were positive for HCV -RNA in serum samples, while in PBMC samples, two patients (1.6%) tested positive for HCV -RNA, of which one patient was anti- HCV IgG Ab positive. Furthermore, the prevalence of OCI was correlated with the history of blood transfusion and serum level of transaminases ( P  = 0.012). The results of the current study suggest that there is a potential risk of occult HCV infection among patients undergoing hemodialysis. Therefore, it is necessary to use appropriate molecular techniques for early diagnosis and treatment of these patients.</description><subject>Antibodies</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Blood levels</subject><subject>blood serum</subject><subject>Blood transfusion</subject><subject>Blood transfusions</subject><subject>Cell Biology</subject><subject>Chronic infection</subject><subject>cross infection</subject><subject>Cross-sectional studies</subject><subject>dialysis</subject><subject>early diagnosis</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Enzymes</subject><subject>females</subject><subject>Gender</subject><subject>Hemodialysis</subject><subject>Hepatitis C</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin M</subject><subject>Infections</subject><subject>Iran</subject><subject>Kidney diseases</subject><subject>kidneys</subject><subject>Leukocytes (mononuclear)</subject><subject>Life Sciences</subject><subject>Liver diseases</subject><subject>males</subject><subject>Microbiology</subject><subject>Original Article</subject><subject>Patients</subject><subject>Peripheral blood mononuclear cells</subject><subject>Population</subject><subject>Population studies</subject><subject>Protein Structure</subject><subject>quantitative polymerase chain reaction</subject><subject>Ribonucleic acid</subject><subject>risk</subject><subject>RNA</subject><subject>Statistical analysis</subject><subject>transaminases</subject><subject>Viral infections</subject><issn>2347-3584</issn><issn>2347-3517</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkc1q3TAQhUVpaEKSF-iiCLpJoU71Z8umq3Dpz4ULyaKlSyGP5FTBlm4l-4J3fYbmDfMkVa7TFLIoXY0YfefMMAehl5ScU0Lku0Q557IgTBSE1DUt5mfoiHEhC15S-fzxXYtDdJrSDSGEUilE1bxAh7wRlZBMHqFfV9HudG89WBw6HACmfsTf7VaPbnQJr_DOxSlh5zsLowsen12u1m-wHoK_ztwQjNP9nDJ6L7F-TO-xxhBDSnc_b9Mi0j1O42Rm3MUw4E2INo3a46sYdi5Pfou_5YaNHq-j9ifooNN9sqcP9Rh9_fjhy-pzsbn8tF5dbApgRMxFayrZclpXzLQVANRgCOddR0GLynDaMA0UWgtAJDOmMbSF1tRM8rbWICQ_RmeL7zaGH1NeQA0uge177W2YkuK0FLRkVLL_QBllNStLkdHXT9CbMMV8gT1FGCUNbzLFFmp_qGg7tY1u0HFWlKj7fNWSr8r5qn2-as6iVw_WUztY8yj5k2YG-AKk_OWvbfw7-x-2vwHEY7Pm</recordid><startdate>202409</startdate><enddate>202409</enddate><creator>Hasanvand, Banafsheh</creator><creator>Mirzaei, Habibollah</creator><creator>Hadian, Babak</creator><creator>sasaei, parsa</creator><creator>Garavand, Sara</creator><creator>Adhikary, Hemanta</creator><creator>Khanizadeh, Sayyad</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope></search><sort><creationdate>202409</creationdate><title>Prevalence of occult hepatitis C virus infection (OCI) among hemodialysis patients; a cross–sectional study from Lorestan Province, Western Iran</title><author>Hasanvand, Banafsheh ; Mirzaei, Habibollah ; Hadian, Babak ; sasaei, parsa ; Garavand, Sara ; Adhikary, Hemanta ; Khanizadeh, Sayyad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c204y-bd67b31862db6ccc8cd033ff1ca46d3192ac1cbecc072dd9d1bcbd8273b8ac473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Blood levels</topic><topic>blood serum</topic><topic>Blood transfusion</topic><topic>Blood transfusions</topic><topic>Cell Biology</topic><topic>Chronic infection</topic><topic>cross infection</topic><topic>Cross-sectional studies</topic><topic>dialysis</topic><topic>early diagnosis</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Enzymes</topic><topic>females</topic><topic>Gender</topic><topic>Hemodialysis</topic><topic>Hepatitis C</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin M</topic><topic>Infections</topic><topic>Iran</topic><topic>Kidney diseases</topic><topic>kidneys</topic><topic>Leukocytes (mononuclear)</topic><topic>Life Sciences</topic><topic>Liver diseases</topic><topic>males</topic><topic>Microbiology</topic><topic>Original Article</topic><topic>Patients</topic><topic>Peripheral blood mononuclear cells</topic><topic>Population</topic><topic>Population studies</topic><topic>Protein Structure</topic><topic>quantitative polymerase chain reaction</topic><topic>Ribonucleic acid</topic><topic>risk</topic><topic>RNA</topic><topic>Statistical analysis</topic><topic>transaminases</topic><topic>Viral infections</topic><toplevel>online_resources</toplevel><creatorcontrib>Hasanvand, Banafsheh</creatorcontrib><creatorcontrib>Mirzaei, Habibollah</creatorcontrib><creatorcontrib>Hadian, Babak</creatorcontrib><creatorcontrib>sasaei, parsa</creatorcontrib><creatorcontrib>Garavand, Sara</creatorcontrib><creatorcontrib>Adhikary, Hemanta</creatorcontrib><creatorcontrib>Khanizadeh, Sayyad</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Virusdisease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasanvand, Banafsheh</au><au>Mirzaei, Habibollah</au><au>Hadian, Babak</au><au>sasaei, parsa</au><au>Garavand, Sara</au><au>Adhikary, Hemanta</au><au>Khanizadeh, Sayyad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of occult hepatitis C virus infection (OCI) among hemodialysis patients; a cross–sectional study from Lorestan Province, Western Iran</atitle><jtitle>Virusdisease</jtitle><stitle>VirusDis</stitle><addtitle>Virusdisease</addtitle><date>2024-09</date><risdate>2024</risdate><volume>35</volume><issue>3</issue><spage>478</spage><epage>483</epage><pages>478-483</pages><issn>2347-3584</issn><eissn>2347-3517</eissn><abstract>Patients with chronic kidney disorders, such as hemodialysis, are at a higher risk of infection with hepatitis viruses than the other population due to high nosocomial transmission by the dialysis units. The incidence of occult HCV infection (OCI) among chronic hemodialysis (CHD) remains controversial and the real burden of HCV in this population may be affected by the rate of OCI. This study aimed to evaluate the prevalence of OCI among patients with CHD from Lorestan province, Western Iran. In this cross-sectional study, whole blood samples were collected from 122 patients with CHD. Subsequently, anti- HCV antibody and HCV -RNA were assessed in serum/peripheral blood mononuclear cells (PBMCs) using Enzyme-Linked Immunosorbent Assay and Real-Time PCR technique, respectively. Out of the 122 patients, 61.15% were male and 38.8% were female. Regarding HCV results, out of the 122 studied patients, 4 cases (3.3%) were positive for anti-HCV IgM Ab and 3 patients (2.47%) for anti- HCV IgG Ab in their serum. Moreover, none of the 122 patients were positive for HCV -RNA in serum samples, while in PBMC samples, two patients (1.6%) tested positive for HCV -RNA, of which one patient was anti- HCV IgG Ab positive. Furthermore, the prevalence of OCI was correlated with the history of blood transfusion and serum level of transaminases ( P  = 0.012). The results of the current study suggest that there is a potential risk of occult HCV infection among patients undergoing hemodialysis. Therefore, it is necessary to use appropriate molecular techniques for early diagnosis and treatment of these patients.</abstract><cop>New Delhi</cop><pub>Springer India</pub><pmid>39464727</pmid><doi>10.1007/s13337-024-00881-y</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2347-3584
ispartof Virusdisease, 2024-09, Vol.35 (3), p.478-483
issn 2347-3584
2347-3517
language eng
recordid cdi_proquest_miscellaneous_3154152172
source SpringerLink Journals
subjects Antibodies
Biochemistry
Biomedical and Life Sciences
Blood levels
blood serum
Blood transfusion
Blood transfusions
Cell Biology
Chronic infection
cross infection
Cross-sectional studies
dialysis
early diagnosis
Enzyme-linked immunosorbent assay
Enzymes
females
Gender
Hemodialysis
Hepatitis C
Immunoglobulin G
Immunoglobulin M
Infections
Iran
Kidney diseases
kidneys
Leukocytes (mononuclear)
Life Sciences
Liver diseases
males
Microbiology
Original Article
Patients
Peripheral blood mononuclear cells
Population
Population studies
Protein Structure
quantitative polymerase chain reaction
Ribonucleic acid
risk
RNA
Statistical analysis
transaminases
Viral infections
title Prevalence of occult hepatitis C virus infection (OCI) among hemodialysis patients; a cross–sectional study from Lorestan Province, Western Iran
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T19%3A38%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20occult%20hepatitis%20C%20virus%20infection%20(OCI)%20among%20hemodialysis%20patients;%20a%20cross%E2%80%93sectional%20study%20from%20Lorestan%20Province,%20Western%20Iran&rft.jtitle=Virusdisease&rft.au=Hasanvand,%20Banafsheh&rft.date=2024-09&rft.volume=35&rft.issue=3&rft.spage=478&rft.epage=483&rft.pages=478-483&rft.issn=2347-3584&rft.eissn=2347-3517&rft_id=info:doi/10.1007/s13337-024-00881-y&rft_dat=%3Cproquest_cross%3E3121282554%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3120210939&rft_id=info:pmid/39464727&rfr_iscdi=true